UNSPSC 51172312: Edetate calcium disodium

This classification denotes a chelating agent with the molecular formula C10H12N2O8.CA.2NA.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 25IH6R4SGF. The term calcium disodium edetate hydrate is a Japanese Accepted Name designation. As of Q4 2014, EDETATE CALCIUM DISODIUM remains the US FDA Preferred Term for this commodity. Edetate calcium disodium bears US NLM identifiers UMLS ID C0006692 and NCI Concept Code C334. SMILES: C(CN(CC(=O)O)CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].[Na+].[Na+].

UNSPSC 51172312 Edetate calcium disodium is a Commodity code that appears in state and local procurement activity as a pass-through designation for drug testing and specimen collection services, particularly in criminal justice supervision contexts, rather than as a primary procurement of the chemical compound itself. The recent solicitation activity under this code reflects state and local governments' direct purchase of integrated drug-testing programs, including specimen collection site staffing, laboratory analysis (immunoassay screening with LC/MS/MS or GC/MS confirmation), result reporting, and alternative testing methodologies such as oral fluid and hair testing. Issuing bodies pursuing these services include county community supervision and corrections departments operating under criminal justice appropriations; the scope encompasses both the administrative and operational infrastructure needed to conduct regular drug-testing programs for offender populations.

Collin County Community Supervision and Corrections Department in Texas posted RFP 2026-327 on September 25, 2026, seeking proposals for offender specimen collection and drug testing services with an original due date of July 23, 2026 and an estimated contract value of $600,000 over two years with three optional one-year renewal periods. The solicitation requires staffing two collection sites in Plano and McKinney for weekday hours and five Saturdays annually, processing approximately 25,031 tests annually across five-panel, six-panel, and ancillary screening formats, and maintaining SAMHSA, Texas Department of Public Safety, or CAP laboratory certification. Pricing is required on a per-test basis across three service models (screening only; confirmation after screening; screening with automatic confirmation of positives), with all costs including freight, delivery, insurance, and staffing, and price redetermination limited to annual September adjustments tied to medical Consumer Price Index increases not exceeding 3.0 percent. The evaluation emphasizes vendor understanding, firm qualifications, client references, and cost, with optional Phase 2 demonstrations and interviews. The anticipated award date is August 10, 2026, with funding derived from Texas Department of Criminal Justice-Community Justice Assistance Division appropriations subject to annual availability.